| |
| |
|
| Insider
Information: |
Mario Ernest |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
1,151,697 |
|
|
Indirect Shares
|
265,510 |
|
|
| Direct
Value |
$8,420,214 |
|
|
|
Indirect Value
|
$116,216 |
|
|
| Total
Shares |
1,417,207 |
|
|
| Total
Value |
$8,536,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -41.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
Director |
– • – |
2006-05-10 |
4 |
B |
$21.30 |
$1,067,377 |
I/I |
50,000 |
50,000 |
2.1 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2018-06-25 |
4 |
B |
$4.48 |
$73,920 |
I/I |
16,500 |
50,000 |
2.1 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2003-09-24 |
4 |
GA |
$0.00 |
$0 |
D/D |
20,833 |
50,431 |
|
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2013-12-13 |
4 |
B |
$13.90 |
$69,500 |
D/D |
5,000 |
51,404 |
2.39 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2014-09-03 |
4 |
B |
$10.55 |
$105,493 |
D/D |
10,000 |
52,500 |
2.39 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2011-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
52,964 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2017-12-15 |
4 |
S |
$3.55 |
$17,750 |
I/I |
(5,000) |
53,500 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2014-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
53,750 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2018-11-26 |
4 |
OE |
$59.06 |
$590,550 |
D/D |
10,000 |
54,413 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-03-05 |
4 |
D |
$85.97 |
$250,001 |
D/D |
(2,908) |
55,005 |
0 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2018-02-23 |
4 |
S |
$94.49 |
$1,263,298 |
D/D |
(13,370) |
55,404 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2017-12-14 |
4 |
S |
$3.58 |
$7,042 |
I/I |
(1,967) |
55,467 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2018-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
300 |
55,704 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2018-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
56,079 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2018-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
334 |
56,413 |
0 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2017-02-27 |
4 |
S |
$121.24 |
$1,454,880 |
D/D |
(12,000) |
57,424 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,100 |
57,913 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2011-03-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(65,832) |
58,244 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2014-04-01 |
4 |
OE |
$5.05 |
$35,587 |
D/D |
7,047 |
58,451 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
484 |
62,209 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
300 |
62,509 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
62,884 |
0 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2012-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
62,964 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2018-12-19 |
4 |
OE |
$59.06 |
$507,873 |
D/D |
8,600 |
63,013 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2017-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
63,822 |
0 |
- |
|
373 Records found
|
|
Page 4 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
